ARS Pharmaceuticals' Neffy Launch Could Be A Hit For Severe Allergic Reactions
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.
Hosted on MSN1d
Keymed’s Stapokibart approved by NMPA for seasonal allergic rhinitis
China's National Medical Products Administration (NMPA) has approved Keymed Biosciences’ supplemental new drug application ...
Prevention on MSN11d
7 Ways to Stop Post-Nasal Drip, According to Doctors
Another natural method that may help you find relief from environmental factors behind your post-nasal drip is by inhaling ...
Rolling Out12d
Why your sore throat could be allergies or something worse
Learn how allergies and other conditions can cause a sore throat, and how to identify the right treatment based on your ...
Seasonal allergy treatments: VERIFY Fact Sheet
Should you start taking your allergy medicine now? We VERIFY the answer to that and other common questions about allergy treatments.
Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...
Lupin gets USFDA approval for nasal spray; share price trade lower
A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...
cnbctv182d
Lupin secures US FDA approval for generic version of Atrovent nasal spray
Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...
Everything you need to know about dust mite allergies as 'life changing' pill offered on NHS
The NHS will now offer immunotherapy pill Acarizax so the body can become less sensitive to dust mites over time and halt ...